Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virally induced immunosuppression.

R M Zinkernagel1, H Hengartner

  • 1University of Zurich, Switzerland.

Current Opinion in Immunology
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

A mouse model reveals how lymphocytic choriomeningitis virus causes immunosuppression by destroying infected cells with T cells. This mechanism may be relevant to acquired immune deficiency syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype.

Blood cells, molecules & diseases·2017
Same author

Reactive oxygen species delay control of lymphocytic choriomeningitis virus.

Cell death and differentiation·2013
Same author

Responses to Cohn's discussion on the Zinkernagel-Hengartner 'Credo 2004'.

Scandinavian journal of immunology·2005
Same author

Port-A-Cath infections in children with cancer.

European journal of cancer (Oxford, England : 1990)·2004
Same author

On immunity against infections and vaccines: credo 2004.

Scandinavian journal of immunology·2004
Same author

Neutralizing antiviral antibody responses.

Advances in immunology·2001
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

Area of Science:

  • Immunology
  • Virology
  • Pathology

Background:

  • Acquired immunosuppression can result from viral infections.
  • T-cell mediated immune responses are crucial in viral clearance and pathogenesis.
  • Lymphocytic choriomeningitis virus (LCMV) is a known viral pathogen affecting immune cells.

Purpose of the Study:

  • To analyze a mouse model of virus-induced T-cell mediated acquired immunosuppression.
  • To elucidate the immunopathological mechanisms underlying LCMV-induced immunosuppression.
  • To explore potential parallels between LCMV infection and acquired immune deficiency syndrome (AIDS).

Main Methods:

  • Utilized a mouse model infected with lymphocytic choriomeningitis virus.
  • Analyzed the roles of macrophages, antigen-presenting cells, and cytotoxic T cells.

Related Experiment Videos

  • Investigated the sequence of cellular destruction and resulting immune suppression.
  • Main Results:

    • LCMV primarily infects macrophages and antigen-presenting cells in the mouse model.
    • LCMV-specific cytotoxic T cells are responsible for the destruction of these infected cells.
    • This targeted cell destruction leads to a state of acquired immunosuppression.

    Conclusions:

    • Virus-triggered, T-cell mediated destruction of immune cells causes acquired immunosuppression.
    • The immunopathological mechanisms observed in LCMV infection may inform our understanding of AIDS.
    • Further research into these mechanisms could reveal therapeutic targets for immune dysfunction.